Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1QTNF9 antisense RNA 1 (C1QTNF9-AS1) is a long non-coding RNA (lncRNA) gene that produces an RNA transcript complementary to the C1QTNF9 mRNA. As a typical antisense RNA, its primary function is likely to regulate the expression of the C1QTNF9 gene post-transcriptionally, typically by hybridizing with the C1QTNF9 mRNA and affecting its stability, splicing, or translation[1][5]. It does not code for a protein, enzyme, receptor, or transporter, and is not itself considered a direct therapeutic target. There are currently no drugs that selectively target this antisense RNA, nor is it widely recognized as a disease biomarker or safety concern in therapeutic development. Key distinction: C1QTNF9-AS1 is the antisense RNA to C1QTNF9, not the C1QTNF9 gene or protein itself. C1QTNF9 encodes a protein (C1q and TNF related protein 9, part of the CTRP family), which plays roles in metabolism and cardiovascular physiology[3][4]. In contrast, C1QTNF9-AS1 is a regulatory RNA influencing the expression of C1QTNF9 and does not have direct receptor or enzymatic function[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C1QTNF9 antisense RNA 1 (C1QTNF9-AS1).